Overview
OutcomesAI augments nursing capacity with AI and licensed nurses. Glia is an AI engine of nurse-focused LLMs and LMMs that handles inbound and outbound patient calls, symptom collection, scheduling, follow-ups, and patient education in multiple languages; it escalates to licensed nurses who use AI-powered tools for real-time scribing, automated documentation, and protocol guidance, all integrated with EHRs. It targets health systems, virtual care providers, and pharmaceutical companies to reduce operational costs by up to 50% and increase nursing capacity by three to five times, without replacing staff. The goal is to address the global nursing shortage and clinician burnout by enabling safer, more scalable patient care at scale, supported by health-system partnerships and a seed round led by Santé Ventures.
Work here?Claim your company
Simplify's take
What believers are saying
- OutcomesAI raised $10 million on 2025-10-01, funding sales expansion.
- The 2026-11-06 CB Insights interview signals active market education and category leadership.
- Vendor claims 3–5x nursing capacity and 58% charting-time reduction, strengthening enterprise ROI pitches.
What critics are saying
- FDA scrutiny intensified after OutcomesAI filed comments on generative-AI medical devices on 2026-10-19.
- Benchmark claims lack published methodology, enabling competitors to challenge 50% cost-reduction promises.
- A major safety incident in nurse triage could trigger hospital exits and kill the company.
What makes OutcomesAI unique
- Glia combines AI voice agents with licensed nurses for hybrid care workflows.
- OutcomesAI integrated with EHRs and launched on 2026-10-03 with multilingual 24/7 coverage.
- Kuldeep Singh Rajput’s Biofourmis pedigree gives healthcare credibility and buyer access.
Help us improve and share your feedback! Did you find this helpful?